-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyntra Bio Inc. publishes corporate presentation on FG-3246 and roxadustat after USD 220 million FibroGen China sale

Reuters·03/11/2026 12:56:24

Please log in to view news